Brawn Biotech Stock Screener | Share Price & Fundamental Analysis
BRAWN
Pharmaceuticals
Screen Brawn Biotech share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹22.29
▲
0.69 (3.19%)
Market Cap
₹5.81 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
2.20
EPS (TTM)
₹-5.68
Dividend Yield
-
Debt to Equity
-
52W High
₹25.40
52W Low
₹15.50
Operating Margin
-33.00%
Profit Margin
-
EBITDA
-
Net Income
-
Total Assets
₹21.00
Total Equity
₹3.00
Brawn Biotech Share Price History - Stock Screener Chart
Screen BRAWN historical share price movements with interactive charts. Analyze price trends and patterns.
Brawn Biotech Company Profile - Fundamental Screener
Screen Brawn Biotech company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for BRAWN shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE899B01015
Brawn Biotech Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen BRAWN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 21 | 15 | 15 | 14 | 14 | 20 | 23 | 23 | 17 | 14 |
| Current Assets | 18 | 13 | 13 | 12 | 13 | 19 | 22 | 22 | 17 | 11 |
| Fixed Assets | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Liabilities | ||||||||||
| Total Liabilities | 21 | 15 | 15 | 14 | 14 | 20 | 23 | 23 | 17 | 14 |
| Current Liabilities | 8 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 3 | 5 | 6 | 7 | 9 | 9 | 9 | 8 | 7 | 6 |
| Share Capital | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Reserves & Surplus | 0 | 2 | 3 | 4 | 6 | 6 | 6 | 5 | 4 | 3 |
Screen BRAWN income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2023-Jun | 2023-Mar | 2022-Jun |
|---|---|---|---|
| Revenue | 0 | 0 | 0 |
| Expenses | 0 | 0 | 0 |
| EBITDA | 0 | 0 | 0 |
| Operating Profit % | -33.00% | 25.00% | 25.00% |
| Depreciation | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 0 |
| EPS | -0.08 | 0.47 | 0.05 |
Brawn Biotech Cash Flow Screener - Liquidity Fundamentals
Screen BRAWN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2 | 1 | 0 |
| Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| Financing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2 | 2 | 0 |
Screen BRAWN shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Sept | 2025-Mar | 2025-Jun | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 53.66% | 53.66% | 53.66% | 53.64% | 53.64% | 53.64% | 53.64% | 53.72% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.35% | 0.35% | 0.35% | 0.35% | 0.35% | 0.35% | 0.35% | 0.59% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 32.90% | 33.17% | 32.88% | 33.91% | 33.96% | 33.84% | 33.20% | 42.70% |
| Other Holding | 13.09% | 12.82% | 13.11% | 12.10% | 12.05% | 12.17% | 12.81% | 2.99% |
| Shareholder Count | 3,958 | 4,024 | 3,975 | 4,160 | 4,090 | 4,157 | 4,060 | 6,222 |
Brawn Biotech Dividend Screener - Share Yield Analysis
Screen BRAWN dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹1.00 | 2.69% |
| 2017-March | ₹1.50 | 2.79% |
| 2016-March | ₹0.00 | 0.00% |
Brawn Biotech Index Membership - Market Screener Classification
Screen BRAWN by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Brawn Biotech Market Events Screener - Corporate Actions
Screen BRAWN market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -13.35% | ||
| Annual General Meeting | NA | 0.10% | ||
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | 9.95% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | -16.28% |
| 2025-05-26 | 2025-05-26 | Quarterly Result Announcement | NA | 1.04% |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | 25.30% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -1.44% |
Brawn Biotech Competitors Screener - Peer Comparison
Screen BRAWN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 412,542 | 39.35 | 54,729 | 9.71% | 10,980 | 39.06 |
| Divis Laboratories | 169,289 | 68.64 | 9,712 | 18.67% | 2,191 | 44.96 |
| Torrent Pharmaceuticals | 129,283 | 60.42 | 11,539 | 6.99% | 1,911 | 59.35 |
| Cipla | 121,626 | 22.17 | 28,410 | 7.12% | 5,291 | 42.76 |
| Dr Reddys Laboratories | 106,207 | 18.42 | 33,741 | 16.73% | 5,725 | 49.97 |
| Lupin | 96,490 | 21.87 | 22,910 | 13.74% | 3,306 | 50.10 |
| Zydus Life Science | 91,909 | 18.03 | 23,511 | 18.55% | 4,615 | 34.06 |
| Mankind Pharma | 90,553 | 50.11 | 12,744 | 20.90% | 2,007 | 40.67 |
| Aurobindo Pharma | 68,837 | 20.16 | 32,346 | 9.43% | 3,484 | 46.33 |
| Alkem Laboratories | 65,737 | 26.89 | 13,458 | 3.70% | 2,216 | 37.45 |
Brawn Biotech Company Announcements - News Screener
Screen BRAWN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-08 | Announcement Under Regulation 30 (LODR) | View |
| 2026-01-05 | Closure of Trading Window | View |
| 2026-01-01 | Announcement under Regulation 30 (LODR)-Resignation of Director | View |
| 2025-11-25 | Announcement under Regulation 30 (LODR)-Cessation | View |
| 2025-11-18 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-17 | Non Applicability For Filing Of Related Party Disclosure | View |
| 2025-11-14 | Results For The Quarter/Half Year Ended 30/09/2025 | View |
| 2025-11-14 | Board Meeting Outcome for Outcome Of Board Meeting | View |
| 2025-11-06 | Board Meeting Intimation for Considering And Approving Inter Alia The Unaudited Financial Results For Quarter End 30 September 2025 | View |
| 2025-10-14 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-30 | Disclosure Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations) | View |
| 2025-09-30 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-30 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-30 | Proceedings Of 40Th Annual General Meeting. | View |
| 2025-09-29 | Closure of Trading Window | View |
| 2025-09-04 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-09-04 | Intimation W.R.T Letter Sent To Shareholders As Per Reg 36 | View |
| 2025-09-03 | Reg. 34 (1) Annual Report. | View |
| 2025-09-03 | Notice Of 40Th Annual General Meeting | View |
| 2025-09-03 | Notice Of 40Th Annual General Meeting | View |